CLINICAL_TRIALS
trial_result
· 2013-12-09
Clinical Trial Update: A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome [Phase 1]
Summary
Phase 1 study of JNJ-30979754 (decitabine) in patients with myelodysplastic syndrome has completed, with results posted in December 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Myelodysplastic Syndrome | Phase 1 | Status: COMPLETED | Results posted: 2013-12-09